(888) 552-6760 SCHEDULE AN APPOINTMENT

Phillip M.D., Kuo,

Ph.D., F.A.C.R.

Diagnostic Radiologist

Biography photo
Location
City of Hope Duarte
1500 East Duarte Road
Duarte, CA 91010
Specialties
Diagnostic Radiology
Education
Medical school:
Board Certifications
  • American Board of Nuclear Medicine

  • Certification Board of Nuclear Cardiology

  • American Board of Radiology

  • Special Certification (CAQ) in Nuclear Radiology

Degrees
  • 2000, M.D., University of Virginia School of Medicine, Charlottesville, Virginia
  • 1999, Ph.D., Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA
  • 1998, M.S. Molecular Physiology and Biological Physics, University of Virginia School of Medicine, Charlottesville, VA
  • 1994, B.A. Chemistry, Harvard University, Cambridge, MA
Fellowship
  • 2003-2004, Nuclear Medicine Fellowship, Yale New Haven Hospital, New Haven, CT
Residency
  • 2005-2008, Diagnostic Radiology Residency, Yale New Haven Hospital, New Haven, CT
  • 2000-2003, Internal Medicine Residency, UCLA Medical Center, Los Angeles, CA
Professional Experience
  • 2024-present, Professor, Division Chief of Nuclear Medicine and Director of Theranostics, Department of Diagnostic Radiology, City of Hope Cancer Center Duarte, CA
  • 2014-2024, Professor for the Departments of Medical Imaging, Medicine and Biomedical Engineering, University of Arizona, Tucson, AZ
  • 2020-2022, Senior Medical Director for Invicro
  • 2013-2020, Program Director for the Nuclear Radiology Fellowship, University of Arizona, Tucson, AZ 
  • 2010-2020, Section Chief of Nuclear Medicine, University of Arizona, Tucson, AZ
  • 2010-2014, Associate Professor of Radiology and Medicine, University of Arizona, Tucson, AZ
  • 2008-2010, Clinical Director of Breast Imaging and Associate Section Head of Nuclear Medicine, Southern Arizona Veterans Administration Hospital, Tucson, AZ, and Associate Professor of Medicine, University of Arizona, Tucson, AZ
  • 2005-2008, Assistant Clinical Professor for Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT
  • 2004-2005, Clinical Instructor for Department of Diagnostic Radiology, Yale University School of Medicine, New Haven, CT
Academic Appointments
  • Professor, Department of Diagnostic Radiology
  • Division Chief of Nuclear Medicine, Department of Diagnostic Radiology
  • Director of Theranostics, Department of Diagnostic Radiology
About Me

Dr. Phillip Kuo is a diagnostic radiologist, chief of the Division of Nuclear Medicine and director of theranostics at City of Hope® Cancer Center Duarte. He is an internationally recognized expert in his field and is known for his work in developing new technologies and therapies that can both detect and treat cancer earlier and more effectively. Over his career, Dr. Kuo has played a key role in designing and leading many important clinical trials funded by both national organizations and private companies. 

Dr. Kuo received his combined M.D. and Ph.D. degrees from the University of Virginia School of Medicine in Charlottesville. He completed his internal medicine training at the University of California, Los Angeles Medical Center, followed by advanced training in nuclear medicine and radiology at Yale New Haven Hospital in Connecticut. Before coming to City of Hope, he served as a professor of medical imaging and biomedical engineering at the University of Arizona, where he also led the nuclear medicine program. 

Dr. Kuo has published more than 140 research articles field, is vice president-elect of the Brain Imaging Council for the Society of Nuclear Medicine and Molecular Imaging and helped found the International Society for Chinese Health Practices.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.